Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00723541 · ClinicalTrials.gov registry record · NA
Breast Lesion Analysis for Tomosynthesis Mammography
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 872
- Enrollment target
NCT00723541: Completed NA study, sponsored by University of Michigan.
NCT00723541 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 872 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00723541, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 872 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a computer-aided diagnosis system to find breast lesions, including masses and microcalcifications, which hopefully will improve breast cancer detection and classification.
Interventions
- PROCEDURE Computer aided analysis of breast lesions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 872 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-07-12 |
| Phase | NA |
What the finished NCT00723541 record still lists
NCT00723541 is an interventional study that assigns participants to a tested intervention. The registered 872 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 1 intervention - of which Computer aided analysis of breast lesions is the first listed.
NCT00723541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00723541 about?
NCT00723541 is a clinical study titled "Breast Lesion Analysis for Tomosynthesis Mammography". The purpose of this study is to develop a computer-aided diagnosis system to find breast lesions, including masses and microcalcifications, which hopefully will improve breast cancer detection and classification.
What is the current status of trial NCT00723541?
This trial is currently completed. It is a NA study. The enrollment target is 872 participants. The study started on 2008-01. Estimated completion is 2016-07-12.
What interventions are being tested in trial NCT00723541?
The interventions under investigation include: Computer aided analysis of breast lesions (PROCEDURE).
Who is sponsoring clinical trial NCT00723541?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00723541's enrollment target sits among peer trials
872 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia